32 related articles for article (PubMed ID: 14609670)
1. Designing Biodegradable Wafers Based on Poly(L-lactide-co-glycolide) and Poly(glycolide-co-ε-caprolactone) for the Prolonged and Local Release of Idarubicin for the Therapy of Glioblastoma Multiforme.
Turek A; Stoklosa K; Borecka A; Paul-Samojedny M; Kaczmarczyk B; Marcinkowski A; Kasperczyk J
Pharm Res; 2020 May; 37(5):90. PubMed ID: 32382838
[TBL] [Abstract][Full Text] [Related]
2. Near-infrared-induced heating of confined water in polymeric particles for efficient payload release.
Viger ML; Sheng W; Doré K; Alhasan AH; Carling CJ; Lux J; de Gracia Lux C; Grossman M; Malinow R; Almutairi A
ACS Nano; 2014 May; 8(5):4815-26. PubMed ID: 24717072
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of hydroxyapatite/polycaprolactone-chitosan composites.
Xiao X; Liu R; Huang Q; Ding X
J Mater Sci Mater Med; 2009 Dec; 20(12):2375-83. PubMed ID: 19572106
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of in vitro drug release, pH change, and molecular weight degradation of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) fibers.
Crow BB; Borneman AF; Hawkins DL; Smith GM; Nelson KD
Tissue Eng; 2005; 11(7-8):1077-84. PubMed ID: 16144443
[TBL] [Abstract][Full Text] [Related]
5. Rheological properties of PLGA film-based implants: correlation with polymer degradation and SPf66 antimalaric synthetic peptide release.
Santoveña A; Alvarez-Lorenzo C; Concheiro A; Llabrés M; Fariña JB
Biomaterials; 2004 Feb; 25(5):925-31. PubMed ID: 14609681
[TBL] [Abstract][Full Text] [Related]
6. Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers.
Elkheshen SA; Radwan MA
J Microencapsul; 2000; 17(4):425-35. PubMed ID: 10898083
[TBL] [Abstract][Full Text] [Related]
7. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.
Kranz H; Ubrich N; Maincent P; Bodmeier R
J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603
[TBL] [Abstract][Full Text] [Related]
8. Degradation behaviour in vitro for poly(D,L-lactide-co-glycolide) as drug carrier.
Lee JS; Chae GS; Kim MS; Cho SH; Lee HB; Khang G
Biomed Mater Eng; 2004; 14(2):185-92. PubMed ID: 15156109
[TBL] [Abstract][Full Text] [Related]
9. Study of the initial stages of drug release from a degradable matrix of poly(d,l-lactide-co-glycolide).
Frank A; Kumar Rath S; Boey F; Venkatraman S
Biomaterials; 2004 Feb; 25(5):813-21. PubMed ID: 14609670
[TBL] [Abstract][Full Text] [Related]
10. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
Jain RA
Biomaterials; 2000 Dec; 21(23):2475-90. PubMed ID: 11055295
[TBL] [Abstract][Full Text] [Related]
11. New methods for direct delivery of chemotherapy for treating brain tumors.
Sawyer AJ; Piepmeier JM; Saltzman WM
Yale J Biol Med; 2006 Dec; 79(3-4):141-52. PubMed ID: 17940624
[TBL] [Abstract][Full Text] [Related]
12. Something new in the field of PLA/GA bioresorbable polymers?
Vert M; Schwach G; Engel R; Coudane J
J Control Release; 1998 Apr; 53(1-3):85-92. PubMed ID: 9741916
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
